What is the dosage and treatment regimen for Diflucan (fluconazole) in treating fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluconazole (Diflucan) Dosage and Treatment Regimens for Fungal Infections

Fluconazole dosing should be tailored to the specific fungal infection type, with dosages ranging from 100-400 mg daily for most systemic infections, with treatment duration determined by clinical response and infection clearance.1

General Dosing Principles

  • Oral absorption of fluconazole is rapid and almost complete, making oral and intravenous doses equivalent 2
  • A loading dose of twice the daily dose is generally recommended on the first day of therapy to achieve steady-state plasma concentrations more quickly 2
  • Treatment should continue until clinical parameters and laboratory tests indicate the active fungal infection has resolved 2

Specific Dosing Regimens by Infection Type

Oropharyngeal Candidiasis

  • 200 mg on first day, followed by 100 mg once daily 2
  • Continue treatment for at least 2 weeks to prevent relapse 2
  • For moderate to severe disease, 100-200 mg daily for 7-14 days 1

Esophageal Candidiasis

  • 200 mg on first day, followed by 100 mg once daily 2
  • Doses up to 400 mg/day may be used based on clinical response 2
  • Minimum treatment duration of 3 weeks and at least 2 weeks following symptom resolution 2

Vaginal Candidiasis

  • Uncomplicated: 150 mg as a single oral dose 2, 3
  • Complicated/severe: Two 150 mg doses given 3 days apart 4
  • Recurrent: 150 mg weekly for 6 months after initial control of the infection 1

Systemic Candida Infections (Candidemia, Disseminated Candidiasis)

  • 400 mg (6 mg/kg) daily, though optimal dosage not fully established 2
  • Treatment should continue for 14 days after documented clearance from bloodstream and resolution of symptoms 1
  • Central venous catheter removal is strongly recommended when possible 1

Urinary Tract Candida Infections

  • Asymptomatic candiduria: Treatment not recommended unless patient is at high risk for dissemination 1
  • Symptomatic cystitis: 200 mg (3 mg/kg) daily for 2 weeks 1
  • Pyelonephritis: 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
  • Patients undergoing urologic procedures: 400 mg (6 mg/kg) daily for several days before and after the procedure 1

Cryptococcal Meningitis

  • Initial treatment: 400 mg on first day, followed by 200 mg once daily 2
  • Dosage may be increased to 400 mg daily based on clinical response 2
  • Treatment duration: 10-12 weeks after cerebrospinal fluid becomes culture negative 2
  • Suppression therapy for AIDS patients: 200 mg once daily 2

Prophylaxis in Bone Marrow Transplant Patients

  • 400 mg once daily 2
  • Begin several days before anticipated onset of neutropenia and continue for 7 days after neutrophil count exceeds 1000 cells/mm³ 2

Special Considerations

Fluconazole-Resistant Infections

  • For fluconazole-resistant Candida glabrata: Consider amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days with or without flucytosine 1
  • For Candida krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1

Pediatric Dosing

  • Dosing should be adjusted based on weight to provide equivalent exposure to adult dosing 2
  • Absolute doses exceeding 600 mg/day are not recommended 2

Common Pitfalls and Caveats

  • Inadequate treatment duration may lead to recurrence of active infection 2
  • Patients with AIDS and cryptococcal meningitis or recurrent oropharyngeal candidiasis usually require maintenance therapy to prevent relapse 2
  • Removal of infected central nervous system devices, including ventriculostomy drains and shunts, is strongly recommended when possible 1
  • Fluconazole has limited efficacy against Aspergillus species at conventional dosages 5
  • For candidal urinary tract infections, elimination of predisposing factors such as indwelling bladder catheters is recommended whenever feasible 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.